Detalhe da pesquisa
1.
Relationship between coronary high-intensity plaques on T1-weighted imaging by cardiovascular magnetic resonance and vulnerable plaque features by near-infrared spectroscopy and intravascular ultrasound: a prospective cohort study.
J Cardiovasc Magn Reson
; 25(1): 4, 2023 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710360
2.
Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study.
Cardiovasc Drugs Ther
; 2023 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097381
3.
Long-term impact of high-sensitivity C-reactive protein in patients with intermittent claudication due to peripheral artery disease following endovascular treatment.
Heart Vessels
; 36(11): 1670-1678, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956183
4.
High Apolipoprotein E Levels Predict Adverse Limb Events in Patients with Peripheral Artery Disease Due to Peripheral Artery Disease Undergoing Endovascular Treatment and On-Statin Treatment.
Int Heart J
; 62(4): 872-878, 2021 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34276016
5.
Long-Term Impact of Renin-Angiotensin System Inhibitors for Secondary Prevention in Patients with Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
Kidney Dis (Basel)
; 10(1): 39-50, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38322627
6.
Impact of simple equation for estimating appendicular skeletal muscle mass in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
Int J Cardiol Heart Vasc
; 44: 101163, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545275
7.
Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention.
J Atheroscler Thromb
; 30(6): 611-623, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934781
8.
Combined impacts of low apolipoprotein A-I levels and reduced renal function on long-term prognosis in patients with coronary artery disease undergoing percutaneous coronary intervention.
Clin Chim Acta
; 536: 180-190, 2022 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36202225
9.
Comparison of clinical outcomes between percutaneous coronary intervention for de novo lesions versus in-stent restenosis lesions.
Cardiovasc Interv Ther
; 37(2): 324-332, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224098
10.
Long-term impact of ß-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
ESC Heart Fail
; 9(1): 545-554, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34811932
11.
Relationship Between Optical Coherence Tomography-Derived In-Stent Neoatherosclerosis and the Extent of Lipid-Rich Neointima by Near-Infrared Spectroscopy and Intravascular Ultrasound: A Multimodal Imaging Study.
J Am Heart Assoc
; 11(23): e026569, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444847
12.
Predictors of discordance between fractional flow reserve and resting full-cycle ratio in patients with coronary artery disease: Evidence from clinical practice.
J Cardiol
; 77(3): 313-319, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234404
13.
Serum apolipoprotein E levels predict residual cardiovascular risk in patients with chronic coronary syndrome undergoing first percutaneous coronary intervention and on-statin treatment.
Atherosclerosis
; 333: 9-15, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34418683
14.
Long-term clinical outcomes and cause of death after endovascular treatment for femoropopliteal artery lesions.
J Cardiol
; 77(4): 417-423, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33229235